LAU 0901

Known as: LAU0901 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2014
0120042014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
The emergence of advanced DNA sequencing methods has presented disruptive opportunities in biotechnology, establishing the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
GABAA receptors are the major inhibitory neurotransmitter receptors in the central nervous system and are the targets of many… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
Introduction: Au-Fe3O4 heterostructures are one of the typical magnetic-based nanocomposites that are usually used in biomedical… (More)
  • figure 2
Is this relevant?
2009
2009
Three transitional-metal-substituted aluminophosphate molecular sieves, |(C3N2H5)8|[M8Al16P24O96] (denoted MAPO-LAU, M = Co, Mn… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2006
2006
OBJECTIVE To evaluate the effect of LAU0901 (2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid ester), a novel platelet… (More)
Is this relevant?
2004
2004
BACKGROUND Surgery is the treatment of choice for thymic epithelial tumors (TET), but the resectability is about 60-70%. For… (More)
Is this relevant?